The aberrant aggregation of α-synuclein in the brain is a hallmark of Parkinson’s disease (PD). In vivo soluble α-synuclein occurs as a monomer and several multimers, the latter of which may be important for the biological function of α-synuclein. Currently, there is a lack of reproducible methods to compare α-synuclein multimer abundance between complex biological samples. Here we developed a method, termed “multimer-PAGE,” that combines in-gel chemical cross-linking with several common electrophoretic techniques to measure the stoichiometry of soluble α-synuclein multimers in brain tissue lysates. Results show that soluble α-synuclein from the rat brain exists as several high molecular weight species of approximately 56 kDa (αS56), 80 kDa...
The protein α-synuclein, a key player in Parkinson's disease (PD) and other synucleinopathies, exist...
Soluble α-synuclein aggregates varying in size, structure, and morphology have been closely linked t...
The protein alpha-synuclein (αS) self-assembles into toxic beta-sheet aggregates in Parkinson’s dise...
The aberrant aggregation of α-synuclein in the brain is a hallmark of Parkinson’s disease (PD). In v...
Despite two decades of research, the structure–function relationships of endogenous, physiological f...
It is now widely recognised that α-Synuclein (αSyn) oligomers are the main pathogenic species in Pa...
Despite two decades of research, the structure–function relationships of endogenous, physiological f...
The pathophysiology of Parkinson’s disease is characterized by the abnormal accumulation of α-synucl...
AbstractAggregation of α-synuclein is involved in the pathogenesis of Parkinson's disease (PD). Stud...
The protein α-synuclein, implicated in Parkinson's disease, was studied by combining nano-electrospr...
β-Sheet-rich aggregates of α-synuclein (αSyn) are the hallmark neuropathology of Parkinson’s disease...
AbstractThere is substantial evidence which implicates α-synuclein and its ability to aggregate and ...
Small oligomers of the protein α-synuclein (αS) are highly cytotoxic species associated with Parkins...
The presynaptic protein α-synuclein (αSyn) aggregates during Parkinson's disease (PD) to form large ...
Funder: Lindemann Trust Fellowship, English-Speaking UnionKnowledge of the mechanisms of assembly of...
The protein α-synuclein, a key player in Parkinson's disease (PD) and other synucleinopathies, exist...
Soluble α-synuclein aggregates varying in size, structure, and morphology have been closely linked t...
The protein alpha-synuclein (αS) self-assembles into toxic beta-sheet aggregates in Parkinson’s dise...
The aberrant aggregation of α-synuclein in the brain is a hallmark of Parkinson’s disease (PD). In v...
Despite two decades of research, the structure–function relationships of endogenous, physiological f...
It is now widely recognised that α-Synuclein (αSyn) oligomers are the main pathogenic species in Pa...
Despite two decades of research, the structure–function relationships of endogenous, physiological f...
The pathophysiology of Parkinson’s disease is characterized by the abnormal accumulation of α-synucl...
AbstractAggregation of α-synuclein is involved in the pathogenesis of Parkinson's disease (PD). Stud...
The protein α-synuclein, implicated in Parkinson's disease, was studied by combining nano-electrospr...
β-Sheet-rich aggregates of α-synuclein (αSyn) are the hallmark neuropathology of Parkinson’s disease...
AbstractThere is substantial evidence which implicates α-synuclein and its ability to aggregate and ...
Small oligomers of the protein α-synuclein (αS) are highly cytotoxic species associated with Parkins...
The presynaptic protein α-synuclein (αSyn) aggregates during Parkinson's disease (PD) to form large ...
Funder: Lindemann Trust Fellowship, English-Speaking UnionKnowledge of the mechanisms of assembly of...
The protein α-synuclein, a key player in Parkinson's disease (PD) and other synucleinopathies, exist...
Soluble α-synuclein aggregates varying in size, structure, and morphology have been closely linked t...
The protein alpha-synuclein (αS) self-assembles into toxic beta-sheet aggregates in Parkinson’s dise...